Company filings profile · CIK 0001785279
Metagenomi Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Metagenomi Therapeutics, Inc. (MGX): 8 filings in the last 90 days vs 16 in the prior 90 (filing-velocity cooling ↓ · 0.5×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 22, 2026. Source-linked, daily-refreshed.
Material 8-K events — Metagenomi Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 22, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Aug 10, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 10, 2026 | Departure/Election of Directors or Officers; Item 5.07 | ↗ |
| May 11, 2026 | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 5, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jan 12, 2026 | Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
Watch Metagenomi Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 22, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 11, 2026 | 4 | 4 | ↗ |
| Sep 10, 2026 | SCHEDULE 13G | ↗ | |
| Sep 10, 2026 | 4 | 4 | ↗ |
| Sep 10, 2026 | 4 | 4 | ↗ |
| Sep 10, 2026 | 4 | 4 | ↗ |
| Aug 10, 2026 | 10-Q | 10-Q | ↗ |
| Aug 10, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jun 11, 2026 | 4 | 4 | ↗ |
| Jun 11, 2026 | 4 | 4 | ↗ |
| Jun 11, 2026 | 4 | 4 | ↗ |
| Jun 11, 2026 | 4 | 4 | ↗ |
| Jun 10, 2026 | 4 | 4 | ↗ |
| Jun 10, 2026 | 4 | 4 | ↗ |
| Jun 10, 2026 | 4 | 4 | ↗ |
| Jun 10, 2026 | 8-K | Departure/Election of Directors or Officers; Item 5.07 | ↗ |
| May 11, 2026 | 10-Q | 10-Q | ↗ |
| May 11, 2026 | 8-K | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 27, 2026 | ARS | ARS | ↗ |
| Apr 27, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 27, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 3, 2026 | 4 | 4 | ↗ |
| Apr 3, 2026 | 4 | 4 | ↗ |
| Apr 3, 2026 | 4 | 4 | ↗ |
| Mar 9, 2026 | 4 | 4 | ↗ |
| Mar 9, 2026 | 4 | 4 | ↗ |
| Mar 9, 2026 | 4 | 4 | ↗ |
| Mar 5, 2026 | S-8 | S-8 | ↗ |
| Mar 5, 2026 | 10-K | 10-K | ↗ |
| Mar 5, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jan 12, 2026 | 8-K | Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Dec 8, 2025 | 4 | 4 | ↗ |
| Dec 8, 2025 | 4 | 4 | ↗ |
| Dec 8, 2025 | 4 | 4 | ↗ |
| Dec 8, 2025 | 4 | 4 | ↗ |
| Dec 1, 2025 | 4 | 4 | ↗ |
| Dec 1, 2025 | 4 | 4 | ↗ |
| Dec 1, 2025 | 4 | 4 | ↗ |
| Dec 1, 2025 | 4 | 4 | ↗ |
| Nov 12, 2025 | 10-Q | 10-Q | ↗ |